Literature DB >> 14735244

[Conservative and interventional endoscopic therapy of biliary tract carcinoma].

K Schoppmeyer1, M Wiedmann, J Mössner, K Caca.   

Abstract

Endoscopic therapy is central to the palliative treatment of bile duct carcinoma. In obstructive jaundice, biliary drainage has few complications and relieves symptoms reliably. It can prevent further complications and is indispensable to the treatment of cholangitis. The principal drawback of biliary stents is stent occlusion and cholangitis. Prophylactic antibiotics were not proven to be effective. Technical details concerning material, number and location of stents await further clarification. Photodynamic therapy is an emerging adjunct to palliative therapy of biliary cancer. Preoperative biliary drainage in obstructive jaundice is not warranted as a routine intervention. It may be indicated, though, as preoperative bridging or to allow liver function to recover before major hepatic surgery. Finally, stenting of postoperative bile duct stenosis is gaining increasing acceptance.

Entities:  

Mesh:

Year:  2004        PMID: 14735244     DOI: 10.1007/s00108-003-1113-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial.

Authors:  U Halm; W E Fleig; J Mössner; V Keim
Journal:  Endoscopy       Date:  2001-06       Impact factor: 10.093

3.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.

Authors:  Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

4.  Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.

Authors:  D González González; D J Gouma; E A Rauws; T M van Gulik; A Bosma; C Koedooder
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

5.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

6.  Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study.

Authors:  Giovanni D De Palma; Angelo Pezzullo; Maria Rega; Marcello Persico; Francesco Patrone; Luigi Mastantuono; Giovanni Persico
Journal:  Gastrointest Endosc       Date:  2003-07       Impact factor: 9.427

Review 7.  A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Authors:  Miguel E Sewnath; Thomas M Karsten; Martin H Prins; Erik J A Rauws; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

8.  Management of occluded biliary Wallstents.

Authors:  T C Tham; D L Carr-Locke; J Vandervoort; R C Wong; D R Lichtenstein; J Van Dam; F Ruymann; S Chow; J J Bosco; T Qaseem; D Howell; D Pleskow; W Vannerman; E D Libby
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

9.  Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage.

Authors:  J Deviere; M Baize; J de Toeuf; M Cremer
Journal:  Gastrointest Endosc       Date:  1988 Mar-Apr       Impact factor: 9.427

10.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.